Terrance D Peabody

Terrance D Peabody, MD serves as Chair of the Department of Orthopaedic Surgery and holds the Edwin Warner Ryerson Professorship at Northwestern University's Feinberg School of Medicine. Board-certified by the American Board of Orthopaedic Surgery, he specializes in orthopaedic oncology with clinical practice at Northwestern Memorial Hospital (Room 13-100, 259 E Erie, Chicago).

Education:

• MD: University of California, Irvine (1985)
• Intern: UC Irvine General Surgery (1986)
• Resident: UC Irvine Orthopaedic Surgery (1990)
• Fellow: University of Chicago Hospitals Orthopaedic Oncology (1991)

Research Focus: Dr. Peabody's work centers on bone tumor biology and sarcoma treatment innovation. His lab investigates socioeconomic determinants of cancer outcomes, virtual reality surgical planning systems, and novel cyst management techniques like Sclerograft™. Current projects address health disparities in musculoskeletal oncology through epidemiological modeling and translational technology development.

Publication Trends: Recent articles (2024-2025) reveal dual emphases on clinical innovation (VR surgical tools, cyst techniques) and systemic healthcare challenges (vulnerability mapping in bone cancer). His work bridges technical surgical advances with population-level health equity analysis, frequently appearing in high-impact journals like Journal of Bone and Joint Surgery.

Scientific Recognition:

• AOA Distinguished Clinician Educator (2020)
• Feinberg School Teaching Award (2016, 2015)

Professional Leadership: As former ABOS Director (2012-2021) and Secretary (2016-2017), he shaped national certification standards. Current memberships include Musculoskeletal Tumor Society (since 1995), American Academy of Orthopaedic Surgeons, and American Orthopaedic Association where he co-chairs leadership development symposia.

Research Ecosystem: He operates within Northwestern's Clinical and Translational Sciences Institute (NUCATS) framework, collaborating with the Musculoskeletal Oncology Research Group. His departmental leadership integrates clinical care, surgical education, and NIH-funded tumor biology initiatives focused on improving sarcoma survival metrics.